Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0451641 (
urolithiasis
)
3,973
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Urolithiasis
, a complex multifactorial disease, results from interactions between environmental and genetic factors. Epidemiological studies have shown the association of
urolithiasis
with a number of lifestyle-related diseases, including cardiovascular diseases, hypertension, chronic kidney disease, diabetes and metabolic syndrome. Elucidation of the mechanisms underlying urinary stone formation will enable development of new preventive treatments. The present article reviews the epidemiology, pathophysiology and potential treatment of
urolithiasis
. Recent literature has shown that oxidative stress and reactive oxygen species could be one such mechanistic pathway. Calcium oxalate crystals adhering to renal tubular cells are incorporated into the cells through the involvement of osteopontin. Stimulation of crystal-cell adhesion impairs acceleration of the mitochondrial permeability transition pore in tubular cells, resulting in mitochondrial collapse, oxidative stress and activation of the apoptotic pathway in the initial steps of renal calcium crystallization. With regard to genetic factors, studies show that single nucleotide polymorphisms in genes encoding
calcium-sensing receptor
, vitamin D receptor and osteopontin are correlated with
urolithiasis
. Genome-wide association studies have shown that CLDN14 and NPT2 are associated with
urolithiasis
in Caucasian and Japanese populations, respectively. Thus, single nucleotide polymorphism analysis would aid in the prediction of
urolithiasis
risk and recurrence. New diagnostic methods and preventive approaches, along with complete removal of stones, will improve the management of
urolithiasis
.
...
PMID:Pathophysiology-based treatment of urolithiasis. 2768 36
Calcium-sensing receptor
(
CaSR
) is a plasma-membrane G protein-coupled receptor activated by extracellular calcium and expressed in kidney tubular cells. It inhibits calcium reabsorption in the ascending limb and distal convoluted tubule when stimulated by the increase of serum calcium levels; therefore, these tubular segments are enabled by
CaSR
to play a substantial role in the regulation of serum calcium levels. In addition,
CaSR
increases water and proton excretion in the collecting duct and promotes phosphate reabsorption and citrate excretion in the proximal tubule. These
CaSR
activities form a network in which they are integrated to protect the kidney against the negative effects of high calcium concentrations and calcium precipitates in urine. Therefore, the
CaSR
gene has been considered as a candidate to explain calcium nephrolithiasis. Epidemiological studies observed that calcium nephrolithiasis was associated with polymorphisms of the
CaSR
gene regulatory region, rs6776158, located within the promoter-1, rs1501899 located in the intron 1, and rs7652589 in the 5'-untranslated region. These polymorphisms were found to reduce the transcriptional activity of promoter-1. Activating rs1042636 polymorphism located in exon 7 was associated with calcium nephrolithiasis and hypercalciuria. Genetic polymorphisms decreasing
CaSR
expression could predispose individuals to stones because they may impair
CaSR
protective effects against precipitation of calcium phosphate and oxalate. Activating polymorphisms rs1042636 could predispose to calcium stones by increasing calcium excretion. These findings suggest that
CaSR
may play a complex role in lithogenesis through different pathways having different relevance under different clinical conditions.
Urolithiasis
2019 Feb
PMID:Calcium-sensing receptor: evidence and hypothesis for its role in nephrolithiasis. 3044 6
A 77-year-old man with a history of hypertension, prostate hyperplasia, and
urolithiasis
was admitted for acute kidney injury caused by hypercalcemia. Neck ultrasonography showed a large cyst adjacent to the right lower thyroid lobe. Although a
99m
technetium sestamibi scan was negative, an extremely high intracystic intact parathyroid hormone level suggested that the cyst had a parathyroid origin and that a functional parathyroid cyst was present. Immunohistochemical staining for the
calcium-sensing receptor
(
CaSR
) after right lower parathyroidectomy revealed
CaSR
-positive cells lining the cyst, indicating that the functional parathyroid cyst had originated from the hemorrhagic degeneration of a parathyroid adenoma.
...
PMID:A Functional Parathyroid Cyst from the Hemorrhagic Degeneration of a Parathyroid Adenoma. 3158 82